The industry says it keeps down the cost of prescription drugs, but critics say it's profiting at the expense of patients.
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.
Cigna's Evernorth Health Services said on Wednesday its actions will enhance transparency about the company's negotiations.
See: FTC takes fresh swipe at drug middlemen, says some prices marked up over 1,000%. Also read: UnitedHealthcare head Brian Thompson's killing shines light on health-insurance denial rates.
Drugmakers hope to see efforts that focus more on cracking down on pharmacy benefit managers while promoting drug innovation ...
Columbus joins the states of Arkansas, California, Kansas, Kentucky, Minnesota and Mississippi and other cities and counties ...
The companies raised prices a median 4%, though some drugs will cost thousands of dollars more.
A proposed Arkansas law would forbid pharmacy benefit managers (PBMs) from holding or acquiring interest in retail pharmacy ...
In 2021, the FDA approved a new insulin drug, Semglee, that was interchangeable with a brand-name insulin called Lantus.